Gleneagles Hospital Chengdu successfully completed two major hepatobiliary surgeries recently that exemplified the clinical and service excellence of our China general surgery team.
Nothing was left to chance as the medical team pored over each patient’s details and medical history when planning and preparing for the two surgeries.
One patient suffered from advanced cholangiocarcinoma and had undergone biliary stent surgery in another hospital. He was presented to our hospital with yellow skin sclera, upper abdominal pain and severe damage to liver function. The general surgery team formulated a targeted diagnosis and treatment plan to protect the liver and eliminate jaundice through infusion, while providing nutritional support to relieve the patient's discomfort.
The second patient was diagnosed with chronic atrophic cholecystitis with gallbladder stones. He had a stone embedded in the neck of the gallbladder as well as gallbladder atrophy. The team developed a personalised care plan for him that included a laparoscopic cholecystectomy.
Both patients are recovering well and receiving good post-operative nutritional care in the hospital. Kudos to our Chengdu medical team for touching the lives of our patients.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
